Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02633189 |
|---|---|
| Brief Title: | Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer (BEVERLY) |
| First Submitted : | December 15, 2015 |
| First Submitted that Met QC Criteria : | December 15, 2015 |
| First Posted : | December 17, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 23, 2023 |
| Last Update Posted : | March 24, 2023 |